Skip to content

Author

E. García-Martín

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Onabotulinum Toxin A (BoNTA) in the Treatment of Chronic and High-Frequency Episodic Migraine: A Real-World Study

Background/Objectives. Although onabotulinumtoxinA (BoNTA) is an established therapy for chronic migraine (CM), its effectiveness in high-frequency episodic migraine (HFEM) remains uncertain. We conducted an 18-year, single-center, retrospective study of patients treated with BoNTA for CM or HFEM. Methods. We included...

F. Jiménez-Jiménez, Alba Cárcamo-Fonfría, Silvina Espada-Rubio et al. · 0 citations
Open access Oct 2026

Lack of Association Between CAT rs1001179 and SOD2 rs4880 Variants and Risk for Multiple Sclerosis

Objectives: Several lines of evidence point to a potential involvement of oxidative stress in the pathophysiology of multiple sclerosis (MS). Superoxide dismutase isoenzymes 1 and 2 (SOD1 and SOD2) and catalase (CAT) are key components of the enzymatic antioxidant defense system. Consequently, genetic variation in the...

E. García-Martín, J. Gómez-Tabales, J. Agúndez et al. · 0 citations
Open access Aug 2026

Lack of Association Between MIR155 Gene Variant rs767649 and Risk for Parkinson’s Disease

Genotype frequencies of the MIR155 rs767649, under codominant, dominant, recessive, and overdominant inheritance models, as well as allelic frequencies, showed no significant differences between PD patients and healthy controls, and the age at PD onset did not differ among the three MIR-155 rs767649 genotypes.

H. Alonso-Navarro, S. Ladera-Navarro, P. Ayuso et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.